key: cord-0784092-idd8uq9h
authors: Zeng, Xianfei; Fan, Hongyan; Lu, Dongxue; Huang, Fang; Meng, Xi; Li, Zhuo; Tang, Mei; Zhang, Jing; Liu, Nannan; Liu, Zhixin; Zhao, Jingya; Yin, Wen; An, Qunxing; Zhang, Xijing; Hu, Xingbin
title: Association between ABO blood groups and clinical outcome of coronavirus disease 2019: Evidence from two cohorts
date: 2020-04-17
journal: nan
DOI: 10.1101/2020.04.15.20063107
sha: 01055f5d7f608ba085234b8e0d9b912bf304acd1
doc_id: 784092
cord_uid: idd8uq9h

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become the third most common coronavirus that causes large-scale infections worldwide. The correlations between pathogen susceptibility and blood type distribution have attracted attention decades ago. The current retrospective study aimed to examine the correlation between blood type distribution and SARS-CoV-2 infection, progression, and prognosis in patients with coronavirus disease 2019 (COVID-19). With 265 patients from multiple medical centers and two established cohorts, we found that the blood type A population was more sensitive to SARS-CoV-2. Moreover, the blood type distribution was not relevant to acute respiratory distress syndrome (ARDS), acute kidney injury (AKI), and mortality in COVID-19 patients. These findings are indicative of coping with the great threat since it probed the relationship between blood types and ARDS, AKI, and mortality, in addition to susceptibility in COVID-19 patients.

In the late part of 2019, a cluster of unexplained pneumonia cases occurred. Patients with fever, cough, and fatigue were diagnosed with a novel coronavirus disease, officially named as COVID- 19 by conducting a retrospective, single-center study of 99 patients [1] . The data indicated that gender, age, and physical condition might be risk . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

factors of COVID-19 outcomes. With regard to SARS in 2003, Cheng and colleagues showed an association between ABO blood group and SARS-CoV infection after exposure [2] . The blood group O population was believed to be less susceptible to SARS. The inherent mechanisms were also investigated, suggesting that human anti-histo-blood group antibodies could block the interaction between the viruses and cells by binding to the spike (S) protein [3] . These results indicate that various factors can affect the spread of coronavirus disease, including blood groups.

Antigens in the blood group system are expressed not only on the surface of human red blood cells, but also on many tissues [4] , which extends the clinical significance of these antigens beyond compatible blood transfusion. Studies on the relationship between the blood group system and human health started in the early 1900s. Blood groups have been associated with the occurrence of several diseases, including cardiovascular disorders, neurological disorders, cancer, and infections [5] [6] . Previous studies have demonstrated that the non-O blood group was associated with increased risk of coronary heart disease through a meta-analysis, which might be due to the high level of von Willebrand factor (vWF) in plasma [7] [8] [9] . Recently, a study of 406,755 unrelated individuals was published by a research group from the Netherlands [10] .

The data indicated that ABO blood group was associated with 11 health . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

problems, especially cardiovascular outcomes. Meo et al. analyzed 15 publications from a public database and found that blood group B was associated with a high risk of type 2 diabetes, while Rh blood groups seemed to have no effect [11] . In addition, Duffy blood group antigens have been shown to be receptors for plasmodium vivax invasion into the red blood cells, which explains the high ratio of the Fy(a-b-) genotype of people in Africa [12] . Overall, these studies suggested that the blood group system was associated with the occurrence of several diseases.

The relationship between blood groups and human diseases is more than a causal association of incidence. Blood groups may influence the progress and outcomes of diseases. The blood type O affects the volumes of grey matter in the cerebellum, which might be associated with the decline in cognitive function [13] . A retrospective study was conducted by a Japanese group to analyze the impact of ABO blood group on outcomes in patients with severe trauma. The results suggested that blood type O was associated with high mortality and less ventilator-free days [14] . Moreover, blood groups have been shown to be relevant to the development and outcomes of chronic heart failure [15] and esophageal squamous cell carcinoma [16] . However, other studies provided conflicting evidence that blood groups were not risk factors for several diseases [17] [18] .

To examine the correlation between blood type distribution and . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

SARS-CoV-2 infection, progression, and prognosis of COVID-19, the current study conducted a retrospective investigation of patients from multiple medical centers.

Two retrospective cohorts diagnosed with COVID-19 were enrolled in this study between February 5 and March 20, 2020. The first cohort comprised patients with mild symptoms admitted in three hospitals in Xi'an, Beijing, and Wuhan. The second cohort comprised critically ill patients from the two hospitals in Xi'an and Wuhan. Five hospitals in this study were assigned by the government as the treatment centers for COVID-19 patients. All study participants were of Chinese Han nationality population and aged >13 years. In the critical cohort, patients were excluded if they died within 24 h upon admission or had current evidence of congestive heart failure, myocardial infarction, or severe isolated head trauma, which was not related to the progress of COVID-19. . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

COVID-19 was defined according to the World Health Organization interim guidance [19] . COVID Demographic data such as age, sex, and medical records including results of laboratory testing, chest radiographs, medical history, and clinical outcomes were collected from all participants. The clinical . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

outcomes (e.g., development of ARDS or AKI, discharged, and mortality) were monitored until the last date of follow-up, March 20, 2020.

Continuous variables were expressed as median (25th and 75th percentiles), while categorical variables were expressed as percentages.

The Mann-Whitney U-test or the Kruskal-Wallis test, as appropriate, were used to compare the medians of continuous variables between or among groups. Categorical data were tested using a Given the limitations of a single factor analysis, we used multivariable logistic regression to further adjust the association of ABO blood type with occurrence of ARDS, AKI, or death for potential confounders, including the common risk factors of age, sex, pre-existing pulmonary disease, history of cardiovascular disease, diabetes mellitus, hypertension, and chronic kidney disease in the critical cohort. The history of diabetes mellitus was selected as a crucial confounder that needs to be adjusted because diabetes was reported to be protective against the development of ARDS, but as a risk factor for AKI and death.

. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

Most importantly, it has been associated with the ABO blood group [24] . Table 4 that had an unadjusted association with ARDS, AKI, death, or ABO blood type at p<0.20 were considered for inclusion in the multivariable models. Additional potential confounders were only included in the final multivariable model if they altered the unadjusted OR for the association between ABO blood type and clinical outcomes by >10% in the bivariate analysis [25] .

For statistical presentation, each blood group was compared with a reference group (blood type O or B). A stratified analysis of a reported region was not performed given that there were no substantial differences in allele distributions and divergent genetic background in participants of Han nationality between different regions. Statistical analyses were performed using SPSS (version 22.0) for Windows. A p-value of <0.05 was considered significant.

In the current study, we enrolled 137 patients with mild pneumonia and 97 patients with severe pneumonia in the mild and critical cohorts, respectively, (Figure 1 ). The demographic data, clinical characteristics, and incidence of ARDS, AKI, and death of the enrolled patients with different blood types are presented in Tables 1 and 2. In this study, the . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

individuals with AB blood type were not statistically analyzed because of the insufficient number of patients (14 in the mild cohort and 5 in the critical cohort). In addition, individuals with blood type AB only accounted for 9.0% of the Chinese population [26] .

In all 234 patients, 133 (56.8%) sufferers were men. When taking age into account, we noticed 67 (57-75) years of age in the critical cohort, and most of them (73.2%) were >60 years of age, but 52 (40-64) and 36.5% in the mild cohort, suggesting that aged sufferers are inclined to develop into the critical ill stage.

All patients in the mild cohort recovered and were discharged.

Approximately 67% of patients diagnosed with severe pneumonia developed ARDS. In critically ill patients, 21 (21.6%) died due to multiple organ failure. There was no difference in the constituent ratios of patient characteristics and outcomes among blood types A, B, and O in the two independent cohorts. Overall, the difference between baseline variables was not statistically significant in the two cohorts in terms of blood type distribution.

We then investigated the potential susceptibility of individuals with different ABO blood types to COVID-19. Table 3 shows the distribution features of the ABO blood types in the mild and critical cohorts. The proportion of blood group A in patients with COVID-19, being 35.76% in . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

the mild cohort and 39.22% in the critical cohort, was significantly higher than that in the reference population (p=0.000 and p=0.005, respectively), which comprised half a million Han Chinese individuals from China [26] .

These results imply that the blood group A population may be more vulnerable to SARS-CoV-2 infection.

In addition, blood type A was associated with increased risk of 

We further explored the relationship between blood type and clinical outcomes of critical patients with severe pneumonia caused by . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

different clinical outcomes in the critical cohort are shown in Table 4 . The age distribution of patients was statistically significant between the ARDS and non-ARDS, AKI and non-AKI, death, and survival groups, thus suggesting that it is closely related to the clinical outcomes and should be included in the logistic model. Although no difference was observed in the gender and the most medical histories between groups, all baseline variables presented in Table 4 were included in the multivariable logistic regression analysis, given their potential influence on patients' clinical outcomes.

In the multivariable logistic regression analysis, which was used to adjust the association of ABO blood type with clinical outcomes for potential confounders, blood type A was not associated with a higher risk for ARDS, AKI, and death relative to blood type O among patients in the critical cohort (Table 5) . Comparisons between blood type A and blood type B did not present any statistically significant associations in the logistic model (data not shown). These data indicate that the blood type of SARS-CoV-2-infected patients is not a potent factor that influences the development and outcome of COVID- 19 CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

age.

The current retrospective investigation found that blood type A individuals were more sensitive to SARS-CoV-2. Although patient age was a factor of mortality in the present study as reported in previous studies [1] , blood type distribution was not a relevant factor of ARDS, AKI, and mortality in COVID-19 patients. To our knowledge, this is the first study to report a conceivable association between ABO blood types and ARDS, AKI, and death risk, and to demonstrate that ABO glycobiology may not play a crucial role in the development of COVID-19. We believe that these findings are indicative since it probed the relationship between blood types and ARDS, AKI, and mortality, in addition to susceptibility or age-related mortality in COVID-19 sufferers.

COVID-19 now posts a great threat to human health worldwide. Thus, global efforts are being made to fight against this serious virus infection.

Recently, scholars have observed that age and gender are correlated with SARS-CoV-2 infection susceptibility or severity [1] . What we found in this study provided some new information from the blood type distribution angle in the mild and critical cohorts. ARDS, AKI, and mortality were not correlated with blood type distribution in COVID-19 patients. Our observations partially clarified the issues regarding the . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

blood type discrimination in the COVID-19 fighting battle. Since blood type is not risk factor for ARDS, AKI, and mortality, average people and health care workers should not overestimate the genetic susceptibility by placing a certain blood group at risk for poor prognosis. This kind of research methods also may be useful for evaluating the relation between blood type and other diseases, such as West Nile virus infection, hepatitis C, diabetes mellitus, and so on. The susceptibility of different ABO blood groups to these diseases has also been investigated [24, 27, 28] , while the progression or prognosis has not been analyzed yet.

The correlation between age, gender, and the susceptibility of SARS-CoV-2 has been investigated in the past several months. What we observed in the current study also confirmed that the aging population are vulnerable to SARS-CoV-2 infection. Consequently, specific preventive measures and therapies should be implemented in the aging population.

In addition, the blood type A population was also more susceptible to SARS-CoV-2 infection, which was consistent with the results of previous similar investigations on West Nile virus infection and plasmodium falciparum susceptibility [27, 29] . Although the sample in our study was relatively small, the data used in the study were obtained from multiple medical centers and may better represent this patient group. Further large-scale investigations are needed to resolve this concern.

Previous reports found that the blood group O population was less . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

susceptible to SARS virus [2] , while we did not obtain the same conclusion in the study on novel coronavirus. Instead, our study demonstrated that blood group A individuals were more susceptible to SARS-CoV-2 infection. We speculate that the main reason is that specific viral protein structure will lead to differences in susceptibility, since the unique virus gene and encoded structure have been resolved [30] .

Furthermore, the previous study was aimed at investigating an individual's inclination to SARS virus infection and was conducted on 45 younger healthcare workers who were exposed to an index SARS patient [2] . It is difficult to determine why the blood type A population is more susceptible to SARS-CoV-2 virus. Actually, in most situations, why some diseases occur in a specific blood type population is not yet clear, except that Duffy blood type defects determine the malaria infection in Africa.

Apart from the regular expression on the red blood cell surface, blood group antigens are also widely distributed on various cells and sometimes in body fluids, including respiratory epithelial cells and alveolar epithelial cells. We believe that the genetic susceptibility of blood type glycophorin may function via receptor-mediated affinity binding, especially in the invasion mechanism. Blood group antigens are proven to be effective receptors for several infectious microorganisms [31] . The specific ABO glycan antigen receptors binding to the virus spike (S) protein may support virus entry during infection.

. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

Given the effects on inflammation, endothelial function, and microvascular coagulation of ABO glycoproteins by changing blood concentrations of soluble ICAM-1, selectins, vWF, and thrombomodulin [32] [33] [34] , the ABO glycans may be important mediators of ARDS or AKI in critically ill patients. Previous studies showed that blood type A was associated with a higher risk of developing ARDS and AKI in the ICU among individuals of European descent, but not in those with African descent [34, 35] . This means that racial divergence and environmental factors may alter the ABO-ARDS or ABO-AKI associations. It is plausible to hypothesize that the existing conclusion drawn in European descent with trauma or severe sepsis may not be applied to the Asian population with COVID-19. Furthermore, there is insufficient evidence regarding the pathophysiologic mechanism and features of ARDS or AKI that occurs secondary to SARS-CoV-2 infection [32] [33] [34] [35] .

The present study has several limitations. First, it is not feasible to use a prospective cohort to determine when patients with mild symptoms progress to the critically ill stage, since the epidemic situation was very serious at that time and all the resources were in used for emergency care.

Second, there are no existing wild cohorts with available demographic and clinical characteristics that can be used as a reference group because patients who developed fever without SARS-CoV-2 infection were not identified during the corresponding period. Thus, it is impossible to . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint .

analyze the correlation between blood type distribution and COVID-19 using a multiple-factor model logistic model. We had to use the chi-square test and calculate the OR value to provide an estimate. This strategy cannot rule out the possibility that blood type is the only factor associated with SARS-CoV-2 infection and progression. Our observations were only based on the results of the epidemic data analysis. The biological evidence between blood type and SARS-CoV-2 susceptibility and progression requires further cellular and molecular investigation.

The current retrospective study of two cohorts confirmed that blood type A populations are more susceptible to SARS-CoV-2 infection.

However, the outcomes including ARDS, AKI, and death are poor irrespective of ABO blood group distribution in critically ill patients with COVID-19, although blood type O sufferers are unlikely to progress into the critical stage after SARS-CoV-2 infection. Additionally, our study identified that age is a risk factor for the development of ARDS or death in critically ill patients with COVID-19. These findings are significant since it deeply probed the correlation between blood type and progression or prognosis in addition to susceptibility. With this kind of research, we will be able to support the fight against COVID-19 around the world.

The authors declare that they have no competing interests.

. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04. 15.20063107 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint . (14, 33) Data are shown as n (%) for categorical variables and median (interquartile range) for continuous variables.

. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint . . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint . for the Chinese population are estimated based on previous literature [ 26] . # p=0.000, § p=0.005, compared with the proportion of type A in Chinese population.

.

It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the

The copyright holder for this preprint . Data are shown as n (%) for categorical variables and median (interquartile range) for continuous variables. ARDS, Acute respiratory distress syndrome; AKI, Acute kidney injury.

.

It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the

The copyright holder for this preprint .

It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the

The copyright holder for this preprint 

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

ABO blood group and susceptibility to severe acute respiratory syndrome

Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies

The histo-blood group ABO system and tissue transplantation

Beyond immunohaematology: the role of the ABO blood group in human diseases

ABO blood group and neurodegenerative disorders: more than a casual association

Prospective study of hemostatic factors and incidence of coronary heart disease: the

ABO(H) blood groups and vascular disease: a systematic review and meta-analysis

ABO blood group and risk of coronary heart disease in two prospective cohort studies

Genetically determined ABO blood group and its associations with health and disease

A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor

O' blood type is associated with larger grey-matter volumes in the cerebellum

The impact of blood type O on mortality of severe trauma patients: a retrospective observational study

Clinical impact of ABO and Rhesus D blood type groups in patients with chronic heart failure

Relationship between ABO blood group and clinicopathological factors and their effect on the survival of Japanese patients with esophageal squamous cell carcinoma

ABO blood type does not influence the risk of cardiovascular complications and mortality after vascular surgery

ABO blood types and major outcomes in patients with acute hypoxaemic respiratory failure: A multicenter retrospective cohort study

Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Critically ill patients with 2009 influenza A(H1N1) infection in Canada

Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs

Acute respiratory distress syndrome: the Berlin Definition

ABO and Rhesus blood groups and risk of type 2 diabetes: evidence from the large E3N cohort study

Simulation study of confounder selection strategies

The distribution of ABO blood groups among 56 ethnic groups in China

Blood group A and D negativity are associated with symptomatic West Nile virus infection

Variation in the host ABO blood group may be associated with susceptibility to hepatitis C virus infection

The ABO blood group system and Plasmodium falciparum malaria

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Blood groups in infection and host susceptibility

Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications

Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: A meta-analysis

The ABO histo-blood group and AKI in critically ill patients with trauma or sepsis

ABO blood type A is associated with increased risk of ARDS in whites following both major trauma and severe sepsis